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Introduction and Aims: Exposure of bacteria such as P. aeruginosa, growing
within a bioﬁlm in the lungs of CF patients, to antibiotics during treatment of
recurring pulmonary exacerbations, may result in the development of antibiotic
resistance. The aim of this study was to compare bioﬁlm formation and antibiotic
susceptibility of matched P. aeruginosa isolates cultured from CF sputum before
and after antibiotic treatment of an acute exacerbation of pulmonary infection.
Methods: Bioﬁlm formation (24 hours) by 10 matched pairs of P. aeruginosa
isolates, cultured from sputum samples prior to commencing and at the end
of antibiotic treatment, was assessed by total viable count using the Calgary
Bioﬁlm Device. The susceptibility of these isolates to antibiotics used in the
treatment of CF pulmonary infection (ceftazidime [CAZ], tobramycin [TOB],
piperacillin/tazobactam [PIP/TAZ] and meropenem [MER]) was determined using
E-test® strips.
Results: All isolates formed bioﬁlms with no differences in bioﬁlm formation
apparent between any of the matched pairs of isolates. Prior to commencing antibi-
otic treatment, P. aeruginosa isolates from 8 (CAZ), 10 (TOB), 8 (PIP/TAZ) and 6
(MER) patients were susceptible. Following antibiotic treatment, the susceptibility
status of isolates changed from sensitive to resistant for 3 (CAZ), 2 (TOB), 1
(PIP/TAZ) and 3 (MER) patients.
Conclusion: These results indicate that antibiotic treatment had no effect on the
ability of P. aeruginosa isolates to form bacterial bioﬁlms but in some patients
resulted in the development of antibiotic resistance.
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Chronic lung infections with Pseudomonas aeruginosa have been considered to be
the main cause of death for Cystic Fibrosis (CF) patients. In these infections, these
and other bacterial species may be growing as bioﬁlms that are more resistant to
antibiotic challenge than planktonic cells. In this study, thirty ﬁve P. aeruginosa
strains isolated from sputum sampled from CF patients were assessed for their
ability to form bioﬁlms in vitro. The degree to which these strains were able to
form bioﬁlms was found to differ markedly. This ﬁnding led to the hypothesis that
this phenotypic differentiation may reﬂect a difference at the genomic level between
strains of P. aeruginosa. To test this, Enterobacterial Repetitive Intergenic Consensus
(ERIC)-PCR and RAPD-PCR was used to assess the degree of genomic similarity
between the strains. These molecular proﬁling data as assessed by cluster analysis
separated the thirty ﬁve strains into four distinct groups (A to D). Of these, twelve
strains most able to form bioﬁlms were found in groups C and D. This suggested a
signiﬁcant connection between the bioﬁlm development and the genomic relatedness
in the strains of P. aeruginosa. The signiﬁcance of these ﬁndings is discussed.
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Introduction and Aims: We have shown previously by culture that the lungs
of Cystic Fibrosis (CF) patients are not only chronically infected with known
pathogens, such as Pseudomonas aeruginosa, but also by an array of other bacterial
species, many of which are anaerobes. As P. aeruginosa grows within a bioﬁlm
in the lungs of CF patients and as bioﬁlm formation is considered an important
virulence factor for CF pulmonary infection, the aim of this study was to determine
the ability of anaerobic bacteria to form single and mixed species bioﬁlms with
P. aeruginosa.
Methods: Bioﬁlm formation (24 & 48 hours) by Prevotella melaninogenica and
P. aeruginosa isolates which had been cultured from the same sputum sample was
assessed by total viable count using a micro-titre tray assay. Adherent bioﬁlms were
removed from the wells of the micro-titre tray by scraping and the total viable count
of both isolates determined by serial dilution and plating on selective agars.
Results: Bioﬁlm formation by both isolates was similar when they were grown
alone and in combination for 24 h with the number of adherent bacteria exceeding
107CFU/well. Furthermore, establishment of a P. aeruginosa bioﬁlm (24 h) did not
prevent the formation of a mixed P. aeruginosa/Pr. melaninogenica bioﬁlm (48 h)
when Pr. melaninogenica was added after 24 h and vice-versa.
Conclusion: These results indicate that P. aeruginosa and Pr. melaninogenica
can form mixed species bioﬁlms in vitro when added both simultaneously and
sequentially 24 hours apart.
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In CF sputum, lactate can be found in high concentrations. It may be derived
from bacterial or cellular sources. Here we correlated lactate in sputum of 25
CF patients to their respective lung functions. In addition, we measured lactate in
neutrophils from healthy donors, and in bacterial suspensions of P. aeruginosa,
S. aureus, and B. cenocepacia grown aerobically and anaerobically. Anaerobic
gene expression of P. aeruginosa strain PAO1 was determined using Affymetrix®
microarrays. Lactate concentrations in CF sputum came to 3.0±3.1mmol/L (range
0.2 to 14.1mmol/L). Neither P. aeruginosa, nor B. cenocepacia produced lac-
tate in vitro, whereas S. aureus generated small amounts. The regulation for
P. aeruginosa lactate dehydrogenase genes was not affected signiﬁcantly after one
day of anaerobic growth (ldhA: −3.9-fold, lldA: −1.5-fold, lldD: −2.7-fold). The
main lactate producers were anaerobically grown neutrophils (3.2mmol/L). The
correlation coefﬁcient between lactate in sputum and FEV1 came to r = −0.431
for all patients (r = −0.527 for patients harbouring P. aeruginosa, and r = −0.454
for S. aureus patients). Lactate predominantly stems from neutrophils metabolizing
anaerobically. Anaerobic P. aeruginosa gene regulation corresponds to the missing
lactate production. Lactate may be used as a marker of inﬂammation in CF sputum.
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